Disease modification and Neuroprotection in neurodegenerative disorders

Disease modification and Neuroprotection in neurodegenerative disorders

Abstract Background Disease modifying therapies (DMTs) are urgently needed for neurodegenerative diseases (NDD) such as Alzheimer’s disease (AD) and many other disorders characterized by protein aggregation and neurodegeneration. Despite advances in understanding the neurobiology of NDD, there are n...

Full description

Bibliographic Details
Main Author: Jeffrey Cummings
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Translational Neurodegeneration
Subjects:
Alzheimer’s disease
Frontotemporal dementia
Progressive supranuclear palsy
Corticobasal degeneration
Amyotropic lateral sclerosis
Multiple system atrophy
Online Access:http://link.springer.com/article/10.1186/s40035-017-0096-2

Internet

http://link.springer.com/article/10.1186/s40035-017-0096-2

Similar Items